Table 2

Clinical features of subjects with β MHC mutations classified according to genotype and affected domain of β MHC

Mutation*Number affectedAge at diagnosis (years)Age at death† (years)Deaths age⩽60/deaths age⩽40Myectomy
or NSRT
ECG Estes scoreMLVWT
(mm)
Echo LVH scoreLVEDD
(mm)
LA (mm)
*Missense mutations categorised according to affected functional domain: (0), no change in overall charge of substituted amino acid at affected site; (+), change in overall charge of substituted amino acid at affected site.
†Death includes death, aborted cardiac death (resuscitated cardiac arrest or appropriate implantable cardioverter defibrillator shock), and cardiac transplantation.
Data for diagnosis, age at death, ECG Estes score, MLVWT, echo LVH score, LVEDD, and LA expressed as mean (SD).
Echo, echocardiographic; LA, left atrial diameter; LVEDD, left ventricular end diastolic diameter; MLVWT, maximum left ventricular wall thickness; NA, not applicable; NSRT, non-surgical septal reduction therapy.
Active site (0)
    Ala196Thr342 (4)541/005 (3)27 (4)7 (4)51 (6)54 (4)
    Pro211Leu333 (13)NA0/002 (4)13 (10)1 (1)41 (4)35 (7)
Active site (+)
    Arg249Gln354 (20)770/013 (2)24 (7)6 (1)45 (6)40 (12)
    Arg453Cys266 (31)NA0/0042344562
Actin binding (0)
    Val404Leu1246 (20)57 (25)2/202 (2)14 (6)2 (3)46 (7)37 (6)
    Val411Ile162650/0161853439
Actin binding (+)
    Arg403Gln2033 (21)50 (17)7/243 (2)17 (7)3 (4)48 (9)45 (11)
Light chain binding (+)
    Gly716Arg250 (35)NA0/0072385148
Rod (0)
    Leu908Val2142 (23)62 (17)2/123 (3)18 (8)3 (3)39 (3)38 (10)
Rod (+)
    Arg870Cys545 (7)52 (7)3/014 (0)1674238
    Glu930Lys235 (16)NA0/013 (2)21 (1)6 (1)47 (1)49 (1)
Total7441 (21)56 (17)15/5103 (2)18 (7)4 (3)44 (6)42 (10)